The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism

Published:2020-07-02 Issue:7 Volume:8 Page:245-256
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Thompson Whitney S.¹,Mondal Gourish²,Vanlith Caitlin J.³^ORCID,Kaiser Robert A.²⁴^ORCID,Lillegard Joseph B.⁴⁵^ORCID

Affiliation:

1. Department of Pediatrics, Mayo Clinic, Rochester, MN, USA

2. Department of Surgery, Research Scientist, Mayo Clinic, Rochester, MN, USA

3. MD/PhD student, Mayo Clinic, Rochester, MN, USA

4. Midwest Fetal Care Center, Childrens Hospital of Minnesota, MN, USA

5. Assistant Professor of Surgery, Mayo Clinic, Rochester, MN, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2020.1791082

Reference80 articles.

1. Metabolic liver disease in children

2. Treatment of inborn errors of metabolism

3. Hereditary tyrosinemia type 1 in Turkey: Twenty year single-center experience

4. NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consenso mexicano de tirosinemia tipo 1;Boletín Médico del Hospital Infantil de México;2024-07-13

2. Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation;International Journal of Molecular Sciences;2024-01-17

3. E. coli´s fight against TYROnny: Designing a bacterial strain to tackle tyrosinemia type 1;Journal of Hepatology;2023-11

4. mRNA-Based Approaches to Treating Liver Diseases;Cells;2022-10-21

5. ORGAN THERAPEUTICS DURING EX-SITU DYNAMIC PRESERVATION. A LOOK INTO THE FUTURE;European Journal of Transplantation;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3